Cite

HARVARD Citation

    Sievert, W. et al. (2015). HCV‐infected patients need access now to new direct‐acting antiviral agents to avert liver‐related deaths. Medical journal of Australia. 202 (9), p. 479. [Online]. 
  
Back to record